Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact
- PMID: 29575972
- PMCID: PMC5912291
- DOI: 10.1177/2045894018769874
Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact
Abstract
Atrial arrhythmia (AA) occurrence in pulmonary arterial hypertension (PAH) may determine clinical deterioration and affect prognosis. In this study we assessed AA incidence in idiopathic (IPAH) and systemic sclerosis related PAH (SSc-PAH) and evaluated risk factors, management, and impact on mortality. We collected baseline data from consecutive IPAH or SSc-PAH patients prospectively enrolled in the Johns Hopkins Pulmonary Hypertension Registry between January 2000 and July 2016. During follow-up AA onset, treatment, and outcome were recorded. Among 317 patients (201 SSc-PAH, 116 IPAH), 42 developed AA (19 atrial fibrillation, 10 flutter-fibrillation, 9 atrial flutter, and 4 atrial ectopic tachycardia) with a 13.2% cumulative incidence. Most events were associated with hospitalization (90.5%). Electrical or pharmacological cardioversion was attempted in most cases. Patients with AA had higher right atrial pressure, pulmonary wedge pressure ( P < 0.005), NT-proBNP ( P < 0.05), and thyroid disease prevalence ( P < 0.005). Higher mortality was observed in patients with AA, though not statistically significant (LogRank P = 0.323). Similar long-term mortality between IPAH with AA and SSc-PAH without AA was observed (LogRank P = 0.098). SSc-PAH with AA had the worst prognosis. In PAH patients AA occurrence is a matter of significant concern. Therapeutic strategies aimed at restoring sinus rhythm may represent an important goal.
Keywords: atrial arrhythmias; pulmonary arterial hypertension; systemic sclerosis.
Figures


Similar articles
-
Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.Ann Am Thorac Soc. 2017 May;14(5):682-689. doi: 10.1513/AnnalsATS.201608-655OC. Ann Am Thorac Soc. 2017. PMID: 28282243 Free PMC article.
-
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.Eur Respir J. 2010 Jan;35(1):95-104. doi: 10.1183/09031936.00074309. Epub 2009 Jul 30. Eur Respir J. 2010. PMID: 19643943
-
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.Microvasc Res. 2017 Nov;114:46-51. doi: 10.1016/j.mvr.2017.06.005. Epub 2017 Jun 12. Microvasc Res. 2017. PMID: 28619664
-
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).Curr Rheumatol Rep. 2016 Feb;18(2):10. doi: 10.1007/s11926-015-0560-x. Curr Rheumatol Rep. 2016. PMID: 26841964 Review.
-
Atrial Arrhythmias in Patients With Pulmonary Hypertension.Chest. 2024 Jul;166(1):201-211. doi: 10.1016/j.chest.2024.03.002. Epub 2024 Mar 5. Chest. 2024. PMID: 38453002 Review.
Cited by
-
Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes.Ann Noninvasive Electrocardiol. 2024 Sep;29(5):e70010. doi: 10.1111/anec.70010. Ann Noninvasive Electrocardiol. 2024. PMID: 39205610 Free PMC article. Review.
-
Isolated Left Atrium Morphofunctional Study of an Experimental Pulmonary Hypertension Model in Rats.Arq Bras Cardiol. 2023 Sep;120(10):e20230188. doi: 10.36660/abc.20230188. Arq Bras Cardiol. 2023. PMID: 37878960 Free PMC article. English, Portuguese.
-
Exploring the involvement of TASK-1 in the control of isolated rat right atrium function from healthy animals and an experimental model of monocrotaline-induced pulmonary hypertension.Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3775-3788. doi: 10.1007/s00210-023-02569-4. Epub 2023 Jun 20. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37338577
-
Impact of Underlying Pulmonary Arterial Hypertension on the In-Hospital Outcomes of Patients Admitted Due to Atrial Fibrillation, Atrial Flutter, Ventricular Tachycardia, or First Myocardial Infarction: A Nationwide Analysis (2016-2020).Cureus. 2025 Mar 10;17(3):e80332. doi: 10.7759/cureus.80332. eCollection 2025 Mar. Cureus. 2025. PMID: 40206921 Free PMC article.
-
Bradycardias in Patients with Pulmonary Hypertension-Prevalence, Pathophysiology and Clinical Relevance.J Cardiovasc Dev Dis. 2025 Mar 28;12(4):120. doi: 10.3390/jcdd12040120. J Cardiovasc Dev Dis. 2025. PMID: 40278179 Free PMC article.
References
-
- Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34–41. - PubMed
-
- Medi C, Kalman JM, Ling LH, et al. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electrophysiol 2012; 23: 614–620. - PubMed
-
- Cannillo M, Grosso Marra W, Gili S, et al. Supraventricular arrhythmias in patients with pulmonary arterial hypertension. Am J Cardiol 2015; 116: 1883–1889. - PubMed
-
- Wen L, Sun ML, An P, et al. Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol 2014; 114: 1420–1425. - PubMed
-
- Tongers J, Schwerdtfeger B, Klein G, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007; 153: 127–132. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials